Receptor activity-modifying protein modulation of parathyroid hormone-1 receptor function and signaling

Area of Science:

• Endocrinology
• Molecular Pharmacology
• G-protein-coupled receptor (GPCR) research

Background:

• Receptor activity-modifying proteins (RAMPs) are known modulators of GPCR function.
• The specific impact of RAMPs on parathyroid hormone 1 receptor (PTH1R) signaling and trafficking is not fully understood.

Purpose of the Study:

• To investigate the effects of RAMP2 and RAMP3 on PTH1R function, signaling, and trafficking.
• To explore the potential of targeting PTH1R-RAMP interactions for therapeutic development.

Main Methods:

• Fluorescence resonance energy transfer (FRET) imaging to assess PTH1R-RAMP interactions.
• Cell surface expression assays.
• Measurement of cAMP accumulation, β-arrestin recruitment, and calcium signaling.
• Antibody-capture scintillation proximity assays for G-protein activation.

Main Results:

• PTH1R preferentially interacted with RAMP2 and RAMP3, with RAMP3 reducing PTH1R cell surface expression.
• RAMP2 significantly enhanced PTH1R signaling responses to various PTH and PTH-related protein (PTHrP) ligands.
• RAMP3 attenuated or abolished PTH1R signaling, and RAMP2 modulated G-protein activation in a ligand-dependent manner.

Conclusions:

• RAMP2 and RAMP3 exert distinct and complex regulatory effects on PTH1R signaling and trafficking.
• The PTH1R/RAMP2 complex represents a potential therapeutic target for bone anabolic therapies, utilizing biased agonism and functional selectivity.